glp 1 blood brain barrier glp-1 Annovis' Lead Compound Enhances Cognition Synergistically with Agonist The Relationship Between the Blood-Brain- Barrier – Centrally administered GLP-1 analogue improves

It is the most abundant endogenous antioxidant in the human body, central to Phase II detoxification in the liver, reactive oxygen species (ROS) neutralisation, immune signalling, and maintenance of cellular redox homeostasis

The study limitation The study limitations are the high heterogeneity observed and the small number of studies assessing the time spent in hypoglycemia and hyperglycemia

Approach: His work emphasizes evidence-based microbiome science, long-term safety, and a systems-based understanding of how microbes influence human health.

The effects of GLP-1RAs on breast cancer risk Current evidence indicates that GLP-1RAs not only do not increase the risk of breast cancer but may also be associated with a reduced risk of breast cancer development [30]